← Back to Clinical Trials
Recruiting NCT07062237

A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Infertility
Sponsor UConn Health
Study Type INTERVENTIONAL
Phase N/A
Enrollment 187
Sex ALL
Min Age 18 Years
Max Age 42 Years
Start Date 2025-07
Completion 2026-06
Interventions
Ultrashort abstinenceStandard abstinence

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This research is being done to determine if producing sperm after an ultrashort period of abstinence (1 hour of abstinence) will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothesize that a shorter period of abstinence is effective at improving rates of normal chromosomes among embryos.

Eligibility Criteria

Inclusion Criteria: * Subjects are nonpregnant females ≥ 18 years and ≤ 42 years of age. * Subjects obtain greater than or equal to 6 mature oocytes at the time of oocyte retrieval for ICSI or greater than or equal to 8 oocytes at the time of oocyte retrieval for standard insemination. * Subjects are utilizing standard insemination or ICSI for fertilization. * Subjects are undergoing PGT-A (PGT for aneuploidy) or PGT-M (PGT for monogenic disorders). * Subjects are willing to comply with study protocol and procedures and provide written informed consent. Exclusion Criteria: * Subjects are utilizing donor oocytes, donor sperm, or gestational carrier. * Subjects have a diagnosis of cryptozoospermia (no spermatozoa identified in fresh semen sample). * Subjects are utilizing surgically removed sperm (e.g. via testicular sperm aspiration \[TESA\] or microsurgical epididymal sperm aspiration \[MESA\]). * Subjects are utilizing frozen/thawed sperm, including in cases in which a fresh sample wa

Related Trials

}
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology